אוגמנטין 600 מג5 מל ES ישראל - עברית - Ministry of Health

אוגמנטין 600 מג5 מל es

glaxo smith kline (israel) ltd - amoxicillin as trihydrate; clavulanic acid as potassium salt - אבקה להכנת תרחיף - amoxicillin as trihydrate 600 mg / 5 ml; clavulanic acid as potassium salt 42.9 mg / 5 ml - amoxicillin and enzyme inhibitor - amoxicillin and enzyme inhibitor - augmentin es is indicated for the treatment of acute otitis media in children aged at least 3 months and less than 40 kg body weight, caused or thought likely to be caused by penicillin-resistant streptococcus pneumoniae:consideration should be given to official guidance on the appropriate use of antibacterial agents.

רדיאן B מאסז' ישראל - עברית - Ministry of Health

רדיאן b מאסז'

devries & co. ltd - camphor; capsicum oleoresin; menthol; methyl salicylate - קרם - menthol 2.54 %w/w; camphor 1.43 %w/w; capsicum oleoresin 0.005 %w/w; methyl salicylate 0.42 %w/w - preparations with salicylic acid derivatives - relief of rheumatic pains and mild muscle pains.

אוגמנטין 600 מג5 מל ES ישראל - עברית - Ministry of Health

אוגמנטין 600 מג5 מל es

glaxo smith kline (israel) ltd - amoxicillin as trihydrate; clavulanic acid as potassium salt - אבקה להכנת תרחיף - amoxicillin as trihydrate 600 mg / 5 ml; clavulanic acid as potassium salt 42.9 mg / 5 ml - amoxicillin and enzyme inhibitor

אוגמנטין 600 מג5 מל ES ישראל - עברית - Ministry of Health

אוגמנטין 600 מג5 מל es

glaxo smith kline (israel) ltd - amoxicillin as trihydrate; clavulanic acid as potassium salt - אבקה להכנת תרחיף - amoxicillin as trihydrate 600 mg / 5 ml; clavulanic acid as potassium salt 42.9 mg / 5 ml - amoxicillin and enzyme inhibitor

אוגמנטין 600 מג5 מל ES ישראל - עברית - Ministry of Health

אוגמנטין 600 מג5 מל es

glaxo smith kline (israel) ltd - amoxicillin as trihydrate; clavulanic acid as potassium salt - אבקה להכנת תרחיף - amoxicillin as trihydrate 600 mg / 5 ml; clavulanic acid as potassium salt 42.9 mg / 5 ml - amoxicillin and enzyme inhibitor

לבולק ישראל - עברית - Ministry of Health

לבולק

megapharm ltd - lactulose - תמיסה (פומי) - lactulose 670 mg/ml - lactulose - lactulose - constipation. acute and chronic hepatic encephalopathy.

קסרלטו 15 מג ישראל - עברית - Ministry of Health

קסרלטו 15 מג

bayer israel ltd - rivaroxaban micronized - טבליות מצופות פילם - rivaroxaban micronized 15 mg - rivaroxaban - rivaroxaban - prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age?75 years, diabetes mellitus, prior stroke or transient ischaemic attack. treatment of deep vein thrombosis (dvt),and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults.

קסרלטו 15 מג ישראל - עברית - Ministry of Health

קסרלטו 15 מג

bayer israel ltd - rivaroxaban micronized - טבליות מצופות פילם - rivaroxaban micronized 15 mg - rivaroxaban - rivaroxaban - prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age?75 years, diabetes mellitus, prior stroke or transient ischaemic attack. treatment of deep vein thrombosis (dvt),and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults.

קסרלטו 20 מג ישראל - עברית - Ministry of Health

קסרלטו 20 מג

bayer israel ltd - rivaroxaban micronized - טבליות מצופות פילם - rivaroxaban micronized 20 mg - rivaroxaban - rivaroxaban - prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age?75 years, diabetes mellitus, prior stroke or transient ischaemic attack. treatment of deep vein thrombosis (dvt),and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults.

קסרלטו 20 מג ישראל - עברית - Ministry of Health

קסרלטו 20 מג

bayer israel ltd - rivaroxaban micronized - טבליות מצופות פילם - rivaroxaban micronized 20 mg - rivaroxaban - rivaroxaban - prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age?75 years, diabetes mellitus, prior stroke or transient ischaemic attack. treatment of deep vein thrombosis (dvt),and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults.